Aurangabad, Chennai plants may be sold, not shut: Pfizer tells employees

Both sites will immediately cease manufacturing; the company will exit both sites as soon as possible.

US pharmaceutical major Pfizer has indicated to its employees that the company might look for a buyer for the Chennai and Aurangabad plants it has decided to shut because of non-viability. In a communication to the staff at these plants, where 1,700 people are currently employed, the company has also promised a generous severance package.

“While we are open to exploring all options, including site sale, at this moment we believe a sale that retains colleagues is unlikely. Hence, we are offering an attractive financial-support scheme,” said the firm’s spokesperson in response to a query.

In an internal communication, a copy of